HERPES VIRUS (HHV 2) - ANVISA Registration 10339840256

Access comprehensive regulatory information for HERPES VIRUS (HHV 2) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10339840256 and manufactured by DIASORIN ITALIA S.P.A.. The registration is held by DIASORIN LTDA with validity until Feb 12, 2027.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ORGENTEC DIAGNOSTIKA GMBH, SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10339840256
2 Related Devices
Registration Details
ANVISA Registration Number: 10339840256
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

LIAISON CONTROL HSV 1/2 IgG
Risk Class III

Registration Details

10339840256

25351414539200697

01896764000170

Company Information

Italy
PT: ITÁLIA

Dates and Status

Feb 12, 2007

12/02/2027

09/18/2025 19:00:01

LIAISON CONTROL HSV 1/2 IgG
Risk Class III

Registration Details

10339840256

25351414539200697

01896764000170

Company Information

Dates and Status

Feb 12, 2007

12/02/2027

09/18/2025 19:00:01